Novel clinical and durable immune response patterns suggest addition of GEN-009 may offer additive clinical benefit in combination with PD-1-based...
REDWOOD CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab...
Disease control rate of 67% and overall response rate of 17% in first six evaluable patients with immediate prior progression...
44.0% objective response rate and 10.3-month median progression-free survival observed in non-small cell lung cancer (NSCLC) cohort Phase 3 registration-enabling...
-- Agonist anti-CD40 mAb CDX-1140 demonstrates best-in-class potential; additional expansion cohorts initiated----Axl and CDX-527 programs highlighted-- HAMPTON, N.J., Nov. 09,...
Highlights: Revenue of $145.2 million up 56% sequentially in quarter ended Sept. 30, 2020 GAAP operating income increased $28.7 million...
RTX-240 Demonstrates Promotion of T Cell and Natural Killer Cell Activation and Expansion In Vitro and In Vivo CAMBRIDGE, Mass.,...
44.4% Overall Response Rate (ORR) and Median Duration of Response (DOR) Not Reached at 8.6 Months of Study Follow Up...
Mathias Mandt Mathias Mandt, ZAGENO's vice president of engineering CAMBRIDGE, Mass. and BERLIN, Germany and WROCLAW, Poland, Nov. 09, 2020 (GLOBE...
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
– exoIL-12™ demonstrates tissue-retained pharmacology, enhanced anti-tumor activity, potent M1 myeloid recruitment, and superior T cell responses in vivo –...
ACE1702 demonstrates enhanced cytotoxicity against multiple HER2-expressing cell lines and activity under immunosuppressive conditions ACE1702 maintains activity following cryopreservation oNK...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”,...
NEW HAVEN, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Kleo Pharmaceuticals, Inc., a targeted immunotherapy company developing fully synthetic bispecific...
FARGO, N.D.--(BUSINESS WIRE)--#Aldevron--Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, today announced Shawn McCormick as...
Former Worldwide President of Becton Dickinson Peripheral Intervention Business Unit to Oversee Rapid Commercial Expansion SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical,...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that its Founder, Chairman, and CEO, Joe Kiani, has been honored by the...
The multi-year strategic partnership will enable GenesisCare to offer patients greater access to leading technology, with a plan to explore...
The grant has been awarded to Navenio’s ‘Intelligent Workforce Solution’, to mitigate the impact of COVID-19 on healthcare systems Navenio’s...
Second Complete Remission Observed in a Patient in Cohort 6 Enrollment in Cohort 8 Has Started SEATLLE, WA / ACCESSWIRE...